Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 19% ± 2% | |
plasma cell | 4 studies | 21% ± 8% | |
epithelial cell | 3 studies | 35% ± 5% | |
GABAergic neuron | 3 studies | 30% ± 8% | |
glutamatergic neuron | 3 studies | 38% ± 9% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 5% | |
astrocyte | 3 studies | 25% ± 4% | |
oligodendrocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1856.71 | 459 / 459 | 100% | 8.91 | 1118 / 1118 |
esophagus | 100% | 1479.19 | 1445 / 1445 | 100% | 8.83 | 183 / 183 |
liver | 100% | 2951.20 | 226 / 226 | 100% | 9.56 | 406 / 406 |
ovary | 100% | 2322.69 | 180 / 180 | 100% | 7.21 | 430 / 430 |
pancreas | 100% | 3950.35 | 328 / 328 | 100% | 7.15 | 178 / 178 |
prostate | 100% | 2154.35 | 245 / 245 | 100% | 13.67 | 502 / 502 |
lung | 100% | 2199.20 | 578 / 578 | 100% | 9.19 | 1153 / 1155 |
uterus | 100% | 2319.81 | 170 / 170 | 100% | 9.17 | 458 / 459 |
thymus | 100% | 2887.78 | 653 / 653 | 100% | 9.38 | 602 / 605 |
brain | 99% | 1249.06 | 2620 / 2642 | 100% | 6.72 | 705 / 705 |
adrenal gland | 100% | 2936.99 | 258 / 258 | 99% | 7.86 | 228 / 230 |
kidney | 100% | 1518.04 | 89 / 89 | 99% | 8.74 | 892 / 901 |
bladder | 100% | 1759.95 | 21 / 21 | 98% | 7.05 | 495 / 504 |
stomach | 100% | 1742.94 | 359 / 359 | 96% | 6.41 | 275 / 286 |
intestine | 100% | 1822.29 | 966 / 966 | 96% | 6.13 | 506 / 527 |
skin | 100% | 1957.20 | 1807 / 1809 | 90% | 6.29 | 425 / 472 |
adipose | 100% | 1819.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2048.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1944.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.16 | 1 / 1 |
heart | 97% | 1451.68 | 837 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 4.57 | 28 / 29 |
muscle | 95% | 603.99 | 762 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 62% | 835.63 | 580 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 35% | 1.05 | 28 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035348 | Biological process | acetyl-CoA transmembrane transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008521 | Molecular function | acetyl-CoA transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC33A1 |
Protein name | Solute carrier family 33 member 1 Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1) |
Synonyms | AT1 ACATN |
Description | FUNCTION: Acetyl-CoA transporter that mediates active acetyl-CoA import through the endoplasmic reticulum (ER) membrane into the ER lumen where specific ER-based acetyl-CoA:lysine acetyltransferases are responsible for the acetylation of ER-based protein substrates, such as BACE1 . Necessary for O-acetylation of gangliosides . . |
Accessions | O00400 ENST00000359479.7 A0A2R8YEX5 H7C532 H7C562 ENST00000644094.1 A0A2R8Y359 ENST00000643144.2 ENST00000646424.1 ENST00000475842.5 ENST00000644855.1 A0A2R8YF57 ENST00000468581.2 ENST00000496772.1 H7C577 A0A2R8Y5I5 ENST00000642438.1 |